In vitro evolution of a ribozyme that contains 5-bromouridine.
The Tetrahymena group I ribozyme was modified by replacing all 99 component uridine residues with 5-bromouridine. This resulted in a 13-fold reduction in catalytic efficiency in the RNA-catalyzed phosphoester-transfer reaction compared to the behavior of the unmodified ribozyme. A population of 10(13) variant ribozymes was constructed, each containing 5-bromouridine in place of uridine. Five successive 'generations' of in vitro evolution were carried out, selecting for improved phosphoester transferase activity. The evolved molecules exhibited a 27-fold increase in catalytic efficiency compared to the wild-type bromouridine-containing ribozyme, even exceeding that of the wild-type ribozyme in the non-brominated form. Three specific mutations were found to be responsible for this altered behavior. These mutations enhanced activity in the context of 5-bromouridine, but were detrimental in the context of unmodified uridine. The evolved RNAs not only tolerated but came to exploit the presence of the nucleotide analogue in carrying out their catalytic function.
Dai
X
X
Department of Chemistry, The Skaggs Institute for Chemical Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.
Joyce
G F
GF
D000818:Animals; D001976:Bromouracil / Q000031:analogs & derivatives; D019143:Evolution, Molecular; D016297:Mutagenesis, Site-Directed; D009154:Mutation; D010770:Phosphotransferases / Q000737:chemistry; D016337:RNA, Catalytic / Q000737:chemistry*; D016053:RNA, Protozoan; D013768:Tetrahymena / Q000235:genetics; D014529:Uridine / Q000031:analogs & derivatives* / Q000737:chemistry
D016337:RNA, Catalytic; D016053:RNA, Protozoan; D001976:Bromouracil; D010770:Phosphotransferases; C006824:5-bromouridine; D014529:Uridine